Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients-Reference-Cited by-同舟云学术

Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients

Published:2006-11 Issue:3-4 Volume:16 Page:254-257
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Kirsch Bernhard M.,Haidinger Michael,Zeyda Maximilian,Böhmig Georg A.,Tombinsky Jazek,Mühlbacher Ferdinand,Watschinger Bruno,Hörl Walter H.,Säemann Marcus D.

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference19 articles.

1. The CAMPATH-1 antigen (CDw52);Hale;Tissue Antigens,1990

2. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients;Calne;Lancet,1998

3. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation—efficacy and safety at five years;Watson;Am J Transplant,2005

4. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation;Kottaridis;Blood,2000

5. Dendritic cells and the control of immunity;Banchereau;Nature,1998

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation;British Journal of Clinical Pharmacology;2022-12-09

2. Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom;Transplantation Reviews;2022-04

3. Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation;Clinical Pharmacokinetics;2017-07-01

4. Eight-year follow-up in pediatric living donor kidney recipients receiving alemtuzumab induction;Pediatric Transplantation;2017-06-10

5. The immunological function of CD52 and its targeting in organ transplantation;Inflammation Research;2017-03-10